These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
48. [L-Dopa in the treatment of Parkinson's disease. (Considerations on 51 cases)]. Mazza C; Buffatti PF; Bazzan A; Lion P Fracastoro; 1970; 63(5):768-73. PubMed ID: 5519378 [No Abstract] [Full Text] [Related]
49. [Treatment of Parkinson syndromes with L-Dopa and the association of L-Dopa and a decarboxylase inhibitor]. Guillard A Brux Med; 1972 Oct; 52(10):673-80. PubMed ID: 4656191 [No Abstract] [Full Text] [Related]
50. Treatment of Parkinson's disease with L-dopa: a current appraisal. Kofman O Can Med Assoc J; 1971 Mar; 104(6):483-7. PubMed ID: 5549988 [TBL] [Abstract][Full Text] [Related]
51. Long-term effects of levodopa in the severely disabled patient. Sacks OW; Messeloff CR; Schwartz WF JAMA; 1970 Sep; 213(13):2270. PubMed ID: 5468938 [No Abstract] [Full Text] [Related]
52. Side effects of L-dopa treatment. Greenburg J Pa Med; 1971 Apr; 74(4):55-6. PubMed ID: 5147645 [No Abstract] [Full Text] [Related]
53. [Current treatment of Parkinson syndrome with L-dopa]. Gerstendbrand F; Gründig E; Musiol A Pol Tyg Lek; 1972 May; 27(21):798-800. PubMed ID: 4555002 [No Abstract] [Full Text] [Related]
54. Double-blind, placebo-controlled study of levodopa therapy in Parkinson's disease. Muenter MD Neurology; 1970 Dec; 20(12):Suppl:6-13. PubMed ID: 4921587 [No Abstract] [Full Text] [Related]
55. [Long-term treatment of Parkinsonism with L-dopa]. Presthus J; Holmsen R Tidsskr Nor Laegeforen; 1972 Nov; 92(33):2262-6. PubMed ID: 4630916 [No Abstract] [Full Text] [Related]
56. [Mental disorders in the course of L-dopa treatment]. Reichowa J; Goldsztajn M Psychiatr Pol; 1973; 7(1):87-9. PubMed ID: 4715838 [No Abstract] [Full Text] [Related]
57. Studies on piribedil in Parkinsonism. Lieberman AN; Shopsin B; Brun YL; Boal D; Zolfaghari M Adv Neurol; 1975; 9():399-407. PubMed ID: 125032 [No Abstract] [Full Text] [Related]
58. Cerebrospinal fluid N-acetyl neuraminic acid in Parkinson's disease, before and after L-dopa therapy. Lipman IJ; Papadopoulos NM Dis Nerv Syst; 1973 Jan; 34(1):59-62. PubMed ID: 4709194 [No Abstract] [Full Text] [Related]
59. Long-term treatment of Parkinsonism with L-dopa. Presthus J; Holmsen R Acta Neurol Scand Suppl; 1972; 51():131-2. PubMed ID: 4514340 [No Abstract] [Full Text] [Related]
60. Combined treatment of parkinsonism with L-dopa and amantadine. Godwin-Austen RB; Frears CC; Bergmann S; Parkes JD; Knill-Jones RP Lancet; 1970 Aug; 2(7669):383-5. PubMed ID: 4194690 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]